Laura Brege sold $1.3M of Mirum Pharmaceuticals stock
By AlphaYouPublished Form 4
Brege Laura
Reporting filer
Laura Brege reported selling 14,167 shares of Mirum Pharmaceuticals, Inc. for about $1.3M ($94.21 a share on average). Form 4 filed Nov 13, 2026 lists 4 entries.
See the price move since this trade →
- Disclosed
- Nov 13, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Brege Laura | 2026-11-11 | M | Exercise or conversion | 14167 | 16.71 | 29,870 | 2 days | Filed terms
|
| Common Stock | Brege Laura | 2026-11-11 | S | Sale | 10907 | 94.05 | 18,963 | 2 days | Filed terms
|
| Common Stock | Brege Laura | 2026-11-11 | S | Sale | 3260 | 94.74 | 15,703 | 2 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Brege Laura | 2026-11-11 | M | Exercise or conversion | 14167 | 0 | 0 | 2 days | Filed terms
|
Common Stock
- Owner
- Brege Laura
- Date
- 2026-11-11
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 14167
- Price
- 16.71
- Following holdings
- 29,870
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-11
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 14167
- transaction Price Per Share: 16.71
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 29870
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Brege Laura
- Date
- 2026-11-11
- Code
- S
- Action
- Sale
- Quantity
- 10907
- Price
- 94.05
- Following holdings
- 18,963
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-11
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 10907
- transaction Price Per Share: 94.05
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 18963
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Brege Laura
- Date
- 2026-11-11
- Code
- S
- Action
- Sale
- Quantity
- 3260
- Price
- 94.74
- Following holdings
- 15,703
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-11
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 3260
- transaction Price Per Share: 94.74
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 15703
- direct Or Indirect Ownership: D
- nature Of Ownership:
Stock Option (right to buy) (derivative)
- Owner
- Brege Laura
- Date
- 2026-11-11
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 14167
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 16.71
- transaction Date: 2026-11-11
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 14167
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F3
- expiration Date: 2030-06-10
- underlying Security Title: Common Stock
- underlying Security Shares: 14167
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Brege Laura: Director.
- F1: The weighted average sale price for the transaction reported was $94.05, and the range of prices were between $93.63 and $94.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- F2: The weighted average sale price for the transaction reported was $94.74, and the range of prices were between $94.635 and $94.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- F3: The stock option is fully vested.
Original sources
Prepared automatically from public filing data. Report a correction.